ELI LILLY & Co · Drugmakers

LLY

Low riskNext report: In 2 days (est.)

View price ↗

The short version

A profitable company with growing sales.

Going well

Sales up 48% in the latest quarter vs a year ago
Profitable, keeps 32% of sales as profit
Sales up 45% last year

Money moves

No insider buying or selling in the last 30 days
Institutions added 1.5% to their holdings in the quarter ending June 2026 (2524 bought, 1562 sold)
Held by George Soros (Soros Fund), Ray Dalio (Bridgewater), Stanley Druckenmiller (Duquesne) and 1 more famous investor

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$1,279.57+0.5% that day

Company value: $1.20T; Share price times all shares
Price vs profit (P/E): 42.9x; You pay about $43 for each $1 of yearly profit
Price vs sales: 15.1x; Company value is 15.1 times a year of sales
Dividend yield: 0.5%; Yearly dividend as a share of today's price
Cash vs value: 1%; Cash as a share of company value
Debt vs value: 3%; Debt as a share of company value

From LLY's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$23.0B+48% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $79.7B, up 50% from the 12 months before. Over 5 years, sales grew about 22% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of LLY. Starting points are the company's recent numbers.

Sales growth+30% a yearRecently: +50% a yearProfit margin34%Last 12 months: 33.5%P/E at the end40xToday: 42.9x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$295.8B

Profit in 5 years$100.6B

Price these guesses point to$4,273.40+234% vs $1,279.57 todayAbout +27% a year, before dividends

What today's price needs: with a 34% margin and a 40x P/E, sales would have to grow about 2.1% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/6Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.101.2%
MissDebt under half of equityNot relying on borrowed money.1.54x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.31.7%
MissProfitable every yearSteady profits, not one good year.9 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$16.8B
PassShare count not growingNot diluting owners. Falling means buybacks.-0.6% in 3 years

Revenue: $65.2B; +44.7% vs prior year
5-year growth: +21.6%/yr; revenue, per year
Total debt: $40.9B; 1.54x equity
Current ratio: 1.58x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.